22-32475021-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012179.4(FBXO7):āc.19C>Gā(p.Leu7Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000117 in 1,539,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO7 | NM_012179.4 | c.19C>G | p.Leu7Val | missense_variant | 1/9 | ENST00000266087.12 | NP_036311.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO7 | ENST00000266087.12 | c.19C>G | p.Leu7Val | missense_variant | 1/9 | 1 | NM_012179.4 | ENSP00000266087.7 | ||
FBXO7 | ENST00000420700.5 | n.19C>G | non_coding_transcript_exon_variant | 1/8 | 5 | ENSP00000406155.1 | ||||
FBXO7 | ENST00000425028.5 | n.19C>G | non_coding_transcript_exon_variant | 1/9 | 5 | ENSP00000395823.1 | ||||
FBXO7 | ENST00000492535.1 | n.7C>G | non_coding_transcript_exon_variant | 1/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000371 AC: 5AN: 134610Hom.: 0 AF XY: 0.0000409 AC XY: 3AN XY: 73346
GnomAD4 exome AF: 0.0000123 AC: 17AN: 1387674Hom.: 0 Cov.: 31 AF XY: 0.0000190 AC XY: 13AN XY: 684704
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.19C>G (p.L7V) alteration is located in exon 1 (coding exon 1) of the FBXO7 gene. This alteration results from a C to G substitution at nucleotide position 19, causing the leucine (L) at amino acid position 7 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at